Bertram Pitt MD
Adult Congenital Heart Disease, Heart Failure & Transplantation, Preventive Cardiology
Physician
Join to View Full Profile
1500 East Medical Center Dr3rd Floor Cardiovascular CenterAnn Arbor, MI 48109
Phone+1 888-287-1082
Dr. Pitt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Cardiovascular Disease, 1966 - 1966
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 1960 - 1963
Mount Sinai Beth Israel HospitalInternship, Transitional Year, 1959 - 1960
University of Basel Faculty of MedicineClass of 1959
Certifications & Licensure
MI State Medical License 1978 - 2024
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2017
- CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2017
Clinical Trials
- Beginning a Randomized Evaluation of the AGE Breaker Alagebrium in Diastolic Heart Failure (BREAK-DHF-I) Start of enrollment: 2008 Mar 01
- The Impact of Pomegranate Extract on Chronic Cardiomyopathy Complicated by Renal Insufficiency (ImPrOVE): a Pilot Study Start of enrollment: 2010 Jul 01
Publications & Presentations
PubMed
- 1 citationsA FIDELITY Analysis on Finerenone With SGLT-2i and GLP-1RA in CKD.Ajay K Singh, Stefan D Anker, Bertram Pitt, Peter Rossing, Luis M Ruilope
Kidney International Reports. 2026-03-01 - A Bayesian analysis of finerenone in heart failure with mildly reduced and preserved ejection fraction: a pre-specified analysis of FINEARTS-HF.Alasdair D Henderson, Kieran F Docherty, Atefeh Talebi, Toru Kondo, Mark C Petrie
European Heart Journal. Cardiovascular Pharmacotherapy. 2026-02-16 - Efficacy and Safety of the Kidney Function-Based Finerenone Dosing Strategy Used in FINEARTS-HF.Misato Chimura, Alasdair D Henderson, Pardeep S Jhund, Brian L Claggett, Akshay S Desai
JACC. Heart Failure. 2026-02-02
Journal Articles
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart FailureDeepak L Bhatt, Darren K Mcguire, Jeffrey M Testani, Pablo Lapuerta, Bertram Pitt, The New England Journal of Medicine
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 DiabetesBertram Pitt, MD, The New England Journal of Medicine
- Incidence, Predictors, and Outcome Associations of Dyskalemia in Heart Failure with Preserved, Mid-Range, and Reduced Ejection FractionBertram Pitt, MD, JACC: Cardiovascular Imaging
Authored Content
- Oxford University Press Has Registered This DOI Pre-PublicationOctober 2018
- Declining Risk of Sudden Death in Heart FailureJuly 2017
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure — NEJMSeptember 1999
Press Mentions
Novo vs. KBP Chapter 2: 'Anomalous' Trial ResultsOctober 2nd, 2025- Researchers Discover Why Donor Hearts Fail in Cold Storage — and How to Prevent ItMay 19th, 2025
- 25th Anniversary of a Landmark Study in Coronary RevascularizationOctober 30th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
